A multi-institutional team led by University of Washington scientists have engineered a new vaccine platform combining mRNA ...

A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new ...

A tiny molecule called a nanobody may succeed where today's cancer drugs often fail, according to University of Hawaiʻi at ...

Scientists are designing mRNA vaccines to produce virus-like nanoparticles, which should lead to a more robust immune ...

People are still debating whether the mRNA from COVID-19 vaccines remains in the body longer than it should. Some say it lingers and causes harm, others say that idea just doesn’t hold up. A new ...

The nano-sized messenger cells are hailed for their rejuvenating power—including signaling to the body when to make more ...

The $48 million award, granted through the Advanced Research Projects Agency for Health, will help Kernal take its in vivo ...

Up to 88 percent of the mice in the study remained tumor-free, and the team are now turning their attention to human cancers.

New research has shown that nanobody treatments that block PD-L1 can reduce tumor growth by about 50% in cancers that don't ...

By casting doubt about the promise of mRNA tech, RFK Jr. is slowing progress toward highly effective therapies that could ...

But recently, scientists took inspiration for such a super drug from a quiet corner of the medical world: The small subset of ...

The 2025 Nobel Prize in physiology or medicine has been awarded to a trio of scientists for unraveling how the immune system protects us from thousands of different microbes trying to invade our ...